1. Home
  2. APRE vs PRZO Comparison

APRE vs PRZO Comparison

Compare APRE & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • PRZO
  • Stock Information
  • Founded
  • APRE 2006
  • PRZO 2014
  • Country
  • APRE United States
  • PRZO Israel
  • Employees
  • APRE N/A
  • PRZO N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • PRZO
  • Sector
  • APRE Health Care
  • PRZO
  • Exchange
  • APRE Nasdaq
  • PRZO Nasdaq
  • Market Cap
  • APRE 13.5M
  • PRZO 13.7M
  • IPO Year
  • APRE 2019
  • PRZO 2023
  • Fundamental
  • Price
  • APRE $1.80
  • PRZO $0.69
  • Analyst Decision
  • APRE Strong Buy
  • PRZO
  • Analyst Count
  • APRE 2
  • PRZO 0
  • Target Price
  • APRE $15.50
  • PRZO N/A
  • AVG Volume (30 Days)
  • APRE 21.0K
  • PRZO 364.4K
  • Earning Date
  • APRE 05-13-2025
  • PRZO 03-21-2025
  • Dividend Yield
  • APRE N/A
  • PRZO N/A
  • EPS Growth
  • APRE N/A
  • PRZO N/A
  • EPS
  • APRE N/A
  • PRZO N/A
  • Revenue
  • APRE $1,502,581.00
  • PRZO $932,154.00
  • Revenue This Year
  • APRE N/A
  • PRZO N/A
  • Revenue Next Year
  • APRE N/A
  • PRZO N/A
  • P/E Ratio
  • APRE N/A
  • PRZO N/A
  • Revenue Growth
  • APRE 157.63
  • PRZO 50.22
  • 52 Week Low
  • APRE $1.85
  • PRZO $0.49
  • 52 Week High
  • APRE $6.70
  • PRZO $3.16
  • Technical
  • Relative Strength Index (RSI)
  • APRE 26.70
  • PRZO 31.98
  • Support Level
  • APRE $1.85
  • PRZO $0.70
  • Resistance Level
  • APRE $2.30
  • PRZO $0.78
  • Average True Range (ATR)
  • APRE 0.16
  • PRZO 0.08
  • MACD
  • APRE -0.01
  • PRZO 0.01
  • Stochastic Oscillator
  • APRE 2.50
  • PRZO 5.28

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.

Share on Social Networks: